IndraLab

Statements


2 | 1

No evidence text available

No evidence text available

sparser
"We find that Kv1.5 interacts specifically with the SUMO-conjugating enzyme Ubc9 and is a target for modification by SUMO-1, -2, and -3 in vivo."